Cargando…
Waldenstrom’s Macroglobulinemia: An Update
Waldenstrom Macroglobulinemia is a rare lymphoproliferative disorder with distinctive clinical features. Diagnostic and prognostic characterisation in WM significantly changed with the discovery of two molecular markers: MYD88 and CXCR4. Mutational status of these latter influences both clinical pre...
Autores principales: | Mazzucchelli, Maddalena, Frustaci, Anna Maria, Deodato, Marina, Cairoli, Roberto, Tedeschi, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760071/ https://www.ncbi.nlm.nih.gov/pubmed/29326801 http://dx.doi.org/10.4084/MJHID.2018.004 |
Ejemplares similares
-
Waldenström's macroglobulinemia front line treatment
por: Tedeschi, Alessandra, et al.
Publicado: (2019) -
Identification of a Candidate Gene Set Signature for the Risk of Progression in IgM MGUS to Smoldering/Symptomatic Waldenström Macroglobulinemia (WM) by a Comparative Transcriptome Analysis of B Cells and Plasma Cells
por: Trojani, Alessandra, et al.
Publicado: (2021) -
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
por: Dogliotti, Irene, et al.
Publicado: (2022) -
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities
por: Frustaci, Anna Maria, et al.
Publicado: (2023) -
Waldenstrom macroglobulinemia: prognosis and management
por: Oza, A, et al.
Publicado: (2015)